The cochlea is the essential organ for hearing and includes both auditory sensory hair cells and spiral ganglion neurons. The discovery of inner ear stem cell brings hope to the regeneration of hair cell and spiral ganglion neuron as well as the followed hearing re-establishment. Thus the investigation on characteristics of inner ear stem/progenitor cells and related regulating clue is important to make such regeneration a reality. In addition, attempts have also been made to transplant exogenous stem cells into the inner ear to restore hearing function. In this review, we describe recent advances in the characterization of mammalian inner ear progenitor/stem cells and the mechanisms of regulating their proliferation and differentiation, and summarize studies that have used exogenous stem cells to repair damaged hair cells and neurons in the inner ear.
Introduction
Hearing loss is one of the most prevalent sensory deficits in humans and is usually caused by irreversible damage to hair cells (HCs) and their associated spiral ganglion neurons (SGNs). HC and SGN loss are mainly attributed to genetic factors, aging, and exposure to noise or ototoxic substances [1] [2] [3] . One theoretically feasible way to re-establish auditory physiology is to generate new functional cells to replace the lost sensorial cells [4] . Stem cells have the capability to self-renew and to differentiate into multiple lineages, and significant efforts have been made in recent years to obtain HCs and SGNs from inner ear stem/ progenitor cells, embryonic stem cells (ESCs), and induced pluripotent stem cells (iPSCs) [5] [6] [7] [8] . It is widely accepted that there are stem/ progenitor cells in the inner ear, especially in the organ of Corti, that can give rise to both HCs and supporting cells (SCs), and these cells are broadly referred to as cochlear stem/progenitor cells [9, 10] . Studies have also shown that cells with stem cell properties also exist in the spiral ganglion region and can be differentiated into neurons, and these are referred to as spiral ganglion-derived neural stem cells (SGN-NSCs) [11, 12] . ESCs/iPSCs and other exogenous stem cells can also be used as sources of HCs and SGNs [13, 14] . The identification and expansion of a renewable source of stem/progenitor cells and the induction of these types of cells to differentiate into HCs are important initial steps in the quest to develop promising therapeutic strategies for hearing loss. In this review, we focus on the characteristics of mammalian inner ear stem cells/progenitor cells and the use of those cells to regenerate or replace the sensory HCs and SGNs of the cochlea.
Structure and development of the mammalian cochlea
The mammalian cochlea consists of three chambers, the scala vestibuli, the scala tympani and the cochlear duct (Fig. 1A) [15] . The organ of Corti is housed in the cochlear duct and detects, amplifies, and transforms mechanical sound waves into electrical signals that are communicated to the SGNs via neurotransmitters. The organ of Corti is composed of one row of inner HCs, three rows of outer HCs, and several underlying non-sensory SC subtypes (Deiters' cells, pillar cells, inner phalangeal/border cells, and Hensen's cells) ( inner HC through a single synapse, while Type II SGNs are unmyelinated and receive inputs from several different outer HCs. In addition, recent studies have identified three novel subclasses of type I SGNs based on the analysis of single-cell RNA sequences [16, 17] .
Nearly all of the structures of the cochlea are derived from a thickened ectoderm next to the hind brain referred to as the otic placode [18] . Pax8, Pax2, Sox2, and Sox9 appear to be the earliest markers in this period [19] [20] [21] . As the placodal ectoderm grows, it invaginates to form a pit, which gradually deepens into a cup and finally closes to become the otocyst at embryonic day (E)9.5 in mice [22, 23] . The neuroblasts surrounding the otocyst begin to delaminate at E9, and subsequently form the spiral ganglion. These delaminating cells are characterized by the expression of neurogenin1, and they become postmitotic starting at the base at E9.5-E10.5 and progressing to the apex at E12.5-E13.5 [24, 25] . Differentiation into the various cell types of the organ of Corti then progresses in an apical to basal gradient from E12.5 to E15.5 [26] . Atoh1 appears to be the earliest HC marker, followed by the restricted expression of Myosin 6 and Myosin 7a in HCs [27] [28] [29] . The expression of Sox9 localizes to SCs by E14.5, and Sox2 disappears from HCs by P0 but remains in SCs [30, 31] . The SGNs form synapses with HCs throughout development up to postnatal day (P)12 [32] .
Stem cell properties of fetal and neonatal supporting cells
In the inner ear, stem/progenitor cells can be isolated from neonatal cochlear tissue. Several reports using culture systems have demonstrated the presence of potential cochlear stem/progenitor cells in the postnatal cochlea that have the capacity for sphere formation [33, 34] , most studies have confirmed that stem/progenitor cells of the organ of Corti after birth can be differentiated into SCs and HCs. Although it might be a matter as to whether the specific SCs with proliferation and differentiation capacity can truly be called "stem cells" in the postnatal cochlea, they nevertheless can be regarded as a progenitor cell population with bilineage differentiation potential.
Sphere formation from inner ear cells was first identified in the adult mouse utricle, which is the organ in the inner ear that and responsible for balance [5] . In that work, they used BrdU to label mitotically active cells, and X-gal histochemistry during sphere formation confirmed that the spheres arose from single sensory epithelial cells. These spheres expressed transcripts for developing inner ear markers, including Pax-2, BMP-4, and BMP-7, and could be differentiated into HC-like cells with bundle-like structures that expressed the HC markers Myosin 7a and Espin. Similar cell lines exhibiting the properties of cochlear stem cells have also been obtained from the lesser epithelial ridge epithelia of the neonatal rat cochlea [34] . After birth, cells of the lesser epithelial ridge will give rise to primitive Hensen's and Claudius' cells and other non-HC epithelial cells [35] . Wang et al. cultured spheres from newborn cochlear basilar membrane cells in the presence of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF). The progenitor cell markers Otx2, BMP4, BMP7, and Islet1 were detected in the sphere cells, and the spheres differentiated into cells that expressed HC and SC markers [33] .
Unlike for stem cells residing in the adult utricle, there are only a few reports about stem/progenitor cells from the mature organ of Corti. Two studies demonstrated the existence of progenitor cells in the cochlea of newborn mice, and they found a sharp reduction in their capacity to form spheres over the first 3 postnatal weeks [36, 37] . A recent study reported that there might be progenitor cells in the adult human cochlea because they observed sphere formation from adult human cochlea cells and because in the adult human cochlea there exists a clear population of stem cell marker Abcg2-positive cells [38] . Although Abcg2-positive cells from the neonatal cochlea isolated by fluorescence-activated cell sorting can proliferate into spheres and are capable of differentiating into HC-like cells [39] , confirmation of Abcg2 as a marker of adult inner ear stem cells requires further studies. Another recent study showed that a combination of growth factors and compounds can promote adult mouse Lgr5-positive SCs and human cochlear cells to generate clonal colonies in 3D culture, although adult colony expansion was much weaker than that seen for the colonies from neonatal mouse Lgr5-positive SCs, and only a few cells were seen in each adult colony [7] . While, colonies cultured in differentiation medium containing a Wnt activator and Notch inhibitor give rise to cells that stain positively for the HC marker Myosin 7a, and this brings new hope to adult mammalian cochlear stem/progenitor cell research. At the same time, further studies are required to prove the existence of adult cochlear stem/progenitor cells and to get a more in-depth understanding of their characteristics.
Several proteins, such as Lgr5, Lgr6, and EPCAM, have been identified as markers of cochlear progenitor cells in mice and humans. p27
Kip1 and p75 NGFR -positive post-mitotic SCs purified from the postnatal mouse cochlea retain the ability to proliferate and to differentiate into new HCs in culture [40] . p27 Kip1 is expressed in all SC types, while [39] . Abcg2 expression in the cochlear epithelium is restricted to the SCs, including Deiters', Hensen's, border, and inner phalengeal cells. Recently, several studies have shown that Lgr5-positive SCs can act as progenitor cells in the mammalian cochlea, and these cells possess regenerative capacity during the early postnatal period [9, 10] . Lgr5 has been found to mark stem cells in multiple tissues, including intestine, Fig. 1 . Anatomy of the mammalian cochlea. (A) As shown in a cross section, the cochlea is a spiral-shaped organ with three chambers -the scala vestibuli (the vestibular duct), the scala media (the cochlear duct), and the scala tympani (the tympanic duct). (B) A core component of the cochlea is the organ of Corti that consists a linear array of four rows of hair cells surrounded by supporting cells. One row of inner hair cells and three rows of outer hair cells detect sounds and connect to the brain via the spiral ganglion neurons.
liver, stomach, hair follicles, mammary gland, and taste buds [41] [42] [43] . In the mammalian cochlea, Lgr5 expression starts at E15.5 in the floor epithelium along with co-expression of the prosensory markers Sox2, Jagged1, and p27
Kip1 [44] . At more mature stages, Lgr5 expression is restricted to subsets of SCs, and only the third row of Deiters' cells in the mature organ of Corti shows detectable Lgr5 expression. Zhang et al. reported that Lgr6-positive HC progenitors had a weaker capacity for expansion compared to Lgr5-positive progenitor cells, while Lgr6-positive progenitor cells had a significantly greater capacity to give rise to HCs than Lgr5-positive progenitor cells [45] . A lineage-tracing experiment by crossing Lgr5-EGFP-IRES-CreER mice with floxed-tdTomato mice revealed that Lgr5-positive progenitor cells from the sensory epithelia give rise to HC-like cells and SCs, but not to neurons or glial cells [46] . A recent study used the cochlear prosensory domain markers EPCAM and CD271 to isolate fetal human postmitotic HC progenitors [47] . Cultured EPCAM/CD271 double-positive cells in Matrigel enabled the generation of epithelial colonies that express the stem cell markers SOX9, SOX2, and FBXO2, while Lgr5 expression was not detectable in the colonies. They also showed no detectable expression at postnatal week 8 (W8), and only weak Lgr5 immunostaining at W10 and at W12, while an in situ hybridization assay showed that Lgr5 mRNA was detectable in the prosensory domain region in all cochlear turns at W9. Collectively, these studies suggest that stem/progenitor cells exist in the postnatal mammalian cochlea and might remain in the adult mammalian cochlea.
Mechanisms underlying the proliferation and differentiation of inner ear stem/progenitor cells

Stem/progenitor cells from the sensory epithelium of inner ear
Several important signaling pathways and regulatory factors are involved in the proliferation and fate of the cochlear stem/progenitor cells. Here, we focus on the underlying mechanism concerning the proliferation and differentiation of cochlear stem/progenitor cells ( Fig. 2A) . First, the Wnt pathway is very important for the proliferation of inner ear progenitor cells. Activation of the canonical Wnt signaling pathway leads to expansion of the Sox2-positive prosensory domain, and this might be mediated by the cell cycle regulator cyclin D1 [48] . Treatment with Wnt agonists increases Lgr5-positive progenitor cell expansion and colony-formation capacity in vitro, and overexpression of β-catenin promotes proliferation and leads to expansion of Lgr5-positive cells within the cochlear sensory epithelium [49, 50] . Moreover, Lgr5 and Lgr6 act as receptors for R-spondins that activate the frizzled-Lrp5/6 complex in conjunction with Wnt agonists [51] . These studies have revealed a strong correlation between the Wnt signaling pathway and cochlear progenitor cell expansion.
During inner ear development, fibroblast growth factors (FGFs) have several stage-specific functions. FGF3 and FGF10 have been shown to play a role in inducing the formation of the otic placode and the otic vesicle [52] . FGF9 and FGF20 binding to mesenchymal FGF receptor (FGFR)1 and FGFR2 is required for cochlear progenitor cell proliferation during otic development, and mesenchymal FGFR signaling is sufficient to promote sensory progenitor proliferation, which gives rise to the auditory sensory epithelium [53, 54] . bFGF is regarded as an important factor in the culture of cochlear progenitor cells and can greatly promote sphere formation [5, 55] , and combinations of bFGF, EGF, and insulin-like growth factor-1 (IGF-1) are widely used for culturing inner ear progenitor cells in vitro.
Sonic hedgehog signaling has been reported to play important roles during the development of the inner ear [56, 57] and to promote the proliferation of mouse embryonic inner ear progenitor cells and their differentiation into HCs [58] . Activation of hedgehog signaling enhances the clone-forming ability and sphere expansion in floating culture of postnatal mouse Lgr5-positive progenitors, and it promotes SC proliferation after neomycin treatment in postnatal organ of Corti cultures [59] . In addition to promoting the proliferation of cochlear progenitor cells, Sonic hedgehog signaling has also been reported to promote HC differentiation thorough the Math1-Brn3.1 signaling pathway [59, 72] .
Deletion of p27(kip1), a cell cycle inhibitor, induces cell-cycle reentry in post-mitotic SCs in neonatal mice [60] . Sox2 serves as a key upstream regulator of p27(Kip1) in order to maintain the quiescent state of postmitotic inner pillar cells (a subtype of SCs), and ablation of Sox2 causes IPCs to re-enter the cell cycle and to proliferate [61] . Moreover, SCs in the postnatal Sox2 haplo-insufficient cochlea maintain their proliferative ability, and Sox2 haplo-insufficiency induces increased expansion of the domain of proliferating SCs after damage to the inner ear [62] .
Meanwhile, Bmi1 deletion in the organ of Corti resulted the decreased cell proliferation of otic progenitors in vitro, which is a member of the Polycomb protein family [63, 64] . Furthermore, the absence of Bmi1 leads to reduced proliferation of SCs and Lgr5-positive progenitor cells after neomycin-induced damage in neonatal mice.
Multiple genes and signaling pathways, such as Atoh1 and Notch signaling, play crucial roles in promoting the differentiation of inner ear progenitor cells into HCs. Atoh1 (Math1) was the first gene implicated in initial HC specification during the earliest stages of inner ear HC development, and deletion of Atoh1 leads to the failure to generate cochlear and vestibular HCs [27, 65] . Atoh1 expression in the organ of Corti begins at E13.5, and the absence of Atoh1 at E13.5 causes the death of HCs in all regions, while deletion at E16.5 leads to the death of HCs only in apical regions and to abnormalities of stereocilia formation throughout all of the HCs. Overexpression of Atoh1 induces robust production of extra HCs in the greater epithelial ridge in the postnatal rat cochlea [66] . In postnatal cochlear Lgr5-positive progenitor cells, co-expression of constitutively active forms of β-catenin and Atoh1 causes these cells to proliferate and to differentiate into HCs [67] , while only located medially to the inner HCs in the greater epithelial region. In the neonatal mouse cochlea, overexpression of Atoh1 in Sox2-positive cells induces many SCs to transdifferentiate into HCs with very few mitotically generated HCs in the greater epithelial ridge, and the combination of Atoh1 overexpression and Wnt overexpression along with Notch inhibition causes extensive mitotic HC generation [68] .
Notch signaling plays a crucial role in determining the fate of inner ear stem/progenitor cells, and inhibition of Notch signaling increases the differentiation of HCs from utricle stem cells in P1-3 mice [69] . Moreover, treatment of inner ear stem/progenitor cells from the cochleae of P1-3 mice with Notch inhibitors induces HC differentiation, and inhibition of Notch signaling increases HC number and promotes hearing recovery after noise-induced damage [70] . Genetic and pharmacological inhibition of Notch signaling causes Lgr5-positive progenitor cells to give rise to HCs, especially in the region of the inner pillar cells and third-row Deiters' cells [6, 9] .
Activating Wnt signaling in neonatal Lgr5-positive progenitor cells has been shown to result in proliferation and mitotic generation of HCs [50] , while other studies have shown that activation of Wnt signaling in Lgr5-positive progenitor cells failed to generate new HCs [49, 71] .The controversy over the role of Wnt signaling in HC differentiation also exists for inner ear stem cell-derived organoids, and McLean et al. reported that a combination of Notch inhibitor and Wnt activator induced Lgr5-positive colonies to differentiate into high-purity populations of Atoh1-nGFP HCs [7] , while another study demonstrated that the Wnt activator did not increase the number of HCs in human fetal inner ear organoids, and a Wnt activator combined with a Notch inhibitor resulted in a smaller number of HCs compared to treatment with a Notch inhibitor alone [47] . It is clearly that the activation of Wnt could promote the proliferation of inner ear progenitor cells, but the effects on the differentiation of HCs still need further investigation.
Neural stem cells derived from the spiral ganglion
A recent study used lineage tracing to show that postnatal inner ear progenitors are restricted to the lineages of their respective compartments, and Plp1-positive glia cells derived from the spiral ganglion give rise to SGNs, while Lgr5-positive stem cells residing in the cochlear epithelium are not multipotent and do not form SGNs [46] . Although previous research showed the inner ear stem cells from the newly developed organ of Corti could transdifferentiated into both HCs and SGNs [73, 74] , while, those stem cells were isolated by neurosphere formation from the single cell suspension of the whole cochlea or utricle, without cell sorting based on inner ear epithelial markers, it is possible that the single cell suspension were contaminated with cells from the neural compartment in these studies. Considering that Lgr5 is widely expressed in the cochlear epithelium, whether stem cells derived from the organ of Corti can differentiate into neurons needs further study, although it is known that there are neural stem cells in the spiral ganglia of postnatal mammals. A few cells expressing neural markers can be found in the organ of Corti sensory epithelial spheres under differentiation conditions, and spheres derived from P21 spiral ganglia exhibit self-renewal capability and can differentiate into neurons [74] . Spiral ganglia cells from postnatal mice can give rise to spheres that are genetically labeled with EGFP and DsRed, thus confirming that spiral ganglia spheres represent clones of single sphere-forming cells [75] .
Nestin is expressed during the development of the central nervous system and is commonly regarded as a marker of neural progenitor cells [76, 77] . Several studies have shown that Nestin-positive neural stem cells exist in the mammalian spiral ganglia and are capable of differentiating into neuron and glial cells [78, 79] , while the expression of Nestin and self-renewal capacity decreased significantly as the mice aged. However, in the presence of EGF/IGF, spiral ganglion cells from adult humans aged between 40 and 60 years old aggregated and grew as neurospheres. Cultured with specific growth factors, spiral ganglion neurospheres differentiated into neurons with elongated neurites and into GFAP-positive glia cells [80] . The presence of neural stem cells in the spiral ganglion might serve as a promising source for the regeneration of SGNs.
Studies have also focused on promoting spiral ganglion stem cell proliferation and directed differentiation into neurons. Leukemia inhibitory factor (LIF) treatment helps to maintain a pool of spiral ganglion stem cells and increases the proliferation of neural stem cells, and it also causes an increase in the number of neurons and glia cells when culturing attached neural stem cells in differentiation medium [81] . Although there is no mention of the effect of LIF on the directed differentiation of neural stem cells, another study showed that the longest neurite length of postnatal SGNs was enhanced by LIF alone [82] .
EGF, bFGF, and IGF-1 have also been applied to the culture of SGNNSCs and have been shown to promote the expansion of neurospheres [75, 83] , and these growth factors, in combination or alone, can promote the proliferation of neural stem cells. Under stimulation by brainderived neurotrophic factor (BDNF), SGN-NSCs can differentiate into cells that express the neuron markers Tuj1, NeuN, NF, and NeuroD in adherent culture [11] . Apart from BDNF, glia cell line-derived neurotrophic factor (GDNF) and neurotrophin-3 (NT-3) also induce differentiation of the SGN-NSCs into Tuj1-positive mature neurons and GFAP-positive glia cells [80] .
Valproic acid has been shown to induce neural differentiation of SGN-NSCs from P1 to P14 in mice through elevated Wnt/β-catenin signaling activity [84] and to inhibit the effect of bFGF in suppressing differentiation and maintaining proliferation. Another compound, ferulic acid, has also been reported to improve neurogenic differentiation of SGN-NSCs. In addition to promoting differentiation into neurons and subsequent neurite outgrowth, ferulic acid improves the viability and proliferation of SGN-NSCs [85] . The differentiation of SGN-derived stem cells into neurons does not receive equal focus as inner ear stem/ progenitor cells that differentiate into HCs, and thus further studies are needed to elucidate the underlying mechanisms behind the maintenance and differentiation of SGN-NSCs in order to develop feasible interventions for SGN regeneration (Fig. 2B ).
Transplanting exogenous stem cells into the inner ear
Although studies have shown the existence of SGN-NSCs, SGNs are poorly regenerated in the mammalian inner ear, and several studies have attempted to transplant stem cells to replace injured SGNs. Injection of culture medium containing NSCs from the dorsal telencephalon of embryonic mice into the inner ear after cochlear implantation showed that glia cells that had differentiated from NSCs could be detected in every turn of the cochlea and that they produced BDNF and GDNF in order to support the survival of SGNs after cochlear implantation surgery [86] . Interestingly, fetal dorsal telencephalon NSCs migrated into the injured vestibular sensory epithelia of adult mice and expressed specific HC markers [87] . However, grafted cells were not found in the cochlear sensory epithelium. Another study showed that neural stem cells derived from mouse fetal cerebellar cells had integrated into the spiral ganglion, and cells labeled with neural stem cell markers were also found in the organ of Corti SC layer after noise-induced damage [88] . Cells labeled as neural stem cells in the inner ear region express different markers depending upon their localization; in other words, neural stem cell differentiation is affected by the microenvironment of the inner ear site in which the cells are located.
Transplantation of neural stem cells from the olfactory bulb into the inner ear via the cochlear lateral wall in a degenerated SGN rat model resulted in some of the cells migrating into Rosenthal's canal and differentiating into neurons [89, 90] . Another study also showed that injected olfactory epithelial neural stem cells migrated into Rosenthal's canal near the spiral ganglion cells via the internal lymph of the scala tympani, and these cells released NGF and NT-3 and alleviated hydrogen peroxide-induced neuronal apoptosis [91] . Finally, when differentiated human mesenchymal stem cells were transplanted into the scala tympani of the guinea pig cochlea after 7 days of ouabain-induced injury, some of the SGNs in the cochlea expressed immunoreactivity with human nuclear antibody and improved hearing function [92] .
Neurons derived from iPSCs have also been used as a source of transplantation to replace SGNs in the inner ear. Within 7 days of transplantation of mouse iPSCs into the cochlea, iPSC-derived cells differentiated into neural lineages including glutamatergic neurons [93] . Ex vivo, iPSC-derived neurons have the ability to form synaptic contacts with HCs. A study also transplanted differentiated neurons derived from human iPSCs into guinea pig cochleae. After 7 days' induction of neural differentiation of iPSCs on a 3D collagen matrix, matrix containing the cells was injected into the cochleae [94] .
Two types of otic progenitors induced from human ESCs have the capacity to differentiate in vitro into HC-like cells and auditory neurons. Transplantation of the neuroprogenitors into an auditory neuropathy model restored a population of SGNs and hearing function [95] . Otic epithelial progenitors derived from human iPSCs have also been transplanted into the inner ear to replace lost HCs. Some iPSC-derived epithelial progenitors migrated to the organ of Corti and differentiated into HC-like cells with synaptic connections to SGNs [96] . After induction of differentiation in culture, a fraction of the epithelial progenitors from mouse ESCs could migrate into the cochlea and express HC markers after transplantation [97, 98] . Despite the success of these experiments, further efforts are required to better modulate the terminal fate of exogenous stem cells after transplantation into the inner ear.
Conclusion and challenges
In summary, stem/progenitor cells with different differentiation potential exist in different regions of the fetal and neonatal cochlea, and progenitor cells in the cochlear epithelium can differentiate into HCs and SCs, while progenitors in the spiral ganglion region can differentiate into neurons and glial cells. These cells, which are labeled with specific markers, have the capacity to proliferate and differentiate under specific conditions. In the adult cochlea, however, the presence of a resident population of self-renewable stem/progenitor cells requires further confirmation. Exogenous stem cells, such as central neural stem cells, ESCs, and iPSCs can also be induced to differentiate into HCs and SGNs. Further categorizing these primary progenitor cells based on their differentiation potential and determining the mechanisms and means behind their fate determination will bring new hope for the regeneration of inner ear HCs and SGNs. The presence of these progenitor cells might make it possible to replace damaged or missing cells in situ by genetic or pharmaceutical means. In addition, if the directional differentiation of primary and exogenous stem cells can be well regulated, it might be possible to transplant genotype-stable stem/ progenitor cells in order to restore hearing function. Recent studies of organoids have resulted in many practical uses in stem cell applications, and inner ear organoids from primary inner ear progenitors or ESCs/ iPSCs will provide drug and gene screening platforms for studying stem cell fate and the differentiation into HCs and neurons. In addition, studies of inner ear organoids can provide in vitro models of diseases and can provide a good foundation for developing treatments for inner ear injury and disease.
There are few reports focused on the regeneration of spiral ganglion by manipulating stem cells, furthermore, the regenerated HCs induced by genetic or pharmacologic strategies are only exist during the neonatal or juvenal stage of the mouse, which could not fully mature with function, meanwhile, the new generated HCs could only survive for a relatively short term. There are still multiple obstacles need to be overcame for restoring hearing by promoting the HC regeneration in mammalian. Since the sensory epithelium of cochlea is composed by multiple cell types and forms an identical topological structure, the regeneration of HCs as well as subtypes of supporting cells will still be a great challenge. In addition, the formation of functional synaptic connections between regenerated HCs and spiral neurons are important for hearing recovery, which is still an under-examined area without sufficient investigations. Above all, the hearing recovery based on the progenitors or stem cells strategies has been initiated but in a primary stage, more investigations related to the regulation on self-renewal of progenitors/stem cells, the manipulation on the differentiation of multiple cell types in inner ear, the promotion of synapses formation between new generated HC and neurons, as well as the establishment of cellular maturation and organ function need to be further explored.
Declaration of Competing Interest
The authors declare no potential conflicts of interest.
